Compound ID | 1921
Class: Beta-lactam (cephalosporin, fourth generation)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against many Enterobacteriaceae but vulnerable to higher levels of extended-spectum beta-lactamases (ESBL) |
| Description: | Semisynthetic Cephalosporine, derived from Cephalosporin C |
| Year first mentioned: | 1991 |
| Highest developmental phase: | Approved in Japan |
| Development status: | Approved |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/9571080 |
| Guide to Pharmacology: | cefozopran |
| Citations: |
|